Editor's Note Recently published data from a study by the Centers for Disease Control and Prevention (CDC) finds that 70.6% of COVID-19-positive patients report “always” wearing a mask, 14.4% report “often” wearing a mask, and 3.9% report “never” wearing a mask (See Table: Reported use of cloth face covering or…

Read More

Editor's Note The Joint Commission announced October 14 that, effective October 15, surveyors will evaluate the Centers for Medicare and Medicaid Services (CMS) reporting requirements for COVID-19 testing results in the Laboratory Accreditation Program. Surveyors will review documentation of COVID-19 test result reporting during the Regulatory Review session of an…

Read More

Editor's Note This study led by researchers at the Massachusetts General Hospital and Harvard Medical School, Boston, finds that patients who survive serious COVID-19 infections have a long-lasting immune response against the virus. The study includes a cohort of case patients with known COVID-19 infection (343) and controls (1,548). Blood…

Read More

Editor's Note The Joint Commission on October 7 issued a new Quick Safety that focuses on the use of telehealth to deliver patient care while preventing exposure to COVID-19. Other benefits of telehealth in the Quick Safety include: promoting social distancing monitoring the progression of home-quarantined COVID-19 patients enabling providers…

Read More

Editor's Note This study by researchers from Children’s Mercy Hospital, Kansas City, Missouri, and others found that for four economy-sensitive conditions, increased unemployment was associated with increased pediatric hospitalizations. A 1% increase in unemployment was associated with a: 5% increase in hospitalization for substance abuse 4% increase for diabetes 2%…

Read More

Editor's Note David Nabarro, MD, the World Health Organization’s (WHO’s) special envoy on COVID-19 in a video interview on October 10 urged world leaders to stop using lockdowns as their primary COVID-19 control method. He added that WHO believes the only time a lockdown is justified is to buy time…

Read More

Editor's Note In this double-blind, randomized, placebo-controlled study of IV remdesivir in adults hospitalized with COVID-19 and lower respiratory tract infection, remdesivir was found to be superior to placebo in shortening the time to recovery. A total of 1,062 patients were randomized to either remdesivir (541) or placebo (521). Remdesivir…

Read More

Editor's Note The Centers for Medicare & Medicaid Services (CMS) on October 9 announced that it is taking action to stop labs that are testing for COVID-19 without proper Clinical Laboratory Improvements Amendments (CLIA) certification. The agency has issued 171 cease-and-desist letters to US facilities that were testing for COVID-19…

Read More

Editor's Note New research presented October 12 at UEG [United European Gastroenterology] Week Virtual 2020 shows that delays in colorectal cancer (CRC) screening caused by COVID-19 has resulted in significantly increased mortality rates. Researchers at the University of Bologna, Italy, developed a model to forecast the impact of delayed CRC…

Read More

Editor's Note Leandro Pecchia, PhD, associate professor of biomedical engineering at the University of Warwick, Coventry, UK, has been awarded £13 million (nearly $17 million) for the ODIN project. The project will explore the use of robots and artificial intelligence (AI) to ease pressures on hospitals during recovery from COVID-19…

Read More